name: | Finerenone |
ATC code: | C03DA05 | route: | oral |
n-compartments | 2 |
Finerenone is a nonsteroidal, selective mineralocorticoid receptor antagonist used in the treatment of chronic kidney disease (CKD) associated with type 2 diabetes. It is approved for reducing the risk of kidney function decline, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in this patient group.
Pharmacokinetic parameters reported in healthy adult subjects after oral administration of finerenone.